Treatment and outcomes of IDH1-mutant gliomas in elderly patients
Alexandra Giantini-Larsen(Memorial Sloan Kettering Cancer Center), Evan D. Bander(Cornell University), Anne S. Reiner(Memorial Sloan Kettering Cancer Center), Tejus Bale(Memorial Sloan Kettering Cancer Center), Viviane Tabar(Memorial Sloan Kettering Cancer Center), Zaki Abou-Mrad(Memorial Sloan Kettering Cancer Center), Kenny Yu(Memorial Sloan Kettering Cancer Center)
Cited by 7
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
|Cancer Cell|2020|470